Evidence map›Paper›PMID 39935750›Full record

ArticleContemporary clinical trials communications2025

An application of minimization for ensuring balanced study arms in a group-randomized COVID-19 educational intervention trial.

Xu Zhang, Mohammad H Rahbar, Amirali Tahanan, Cici Bauer, Marcia C de Oliveira Otto, Alanna C Morrison, Belinda Reininger, Maria E Fernandez

Abstract read
In one paragraph

Article in Contemporary clinical trials communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xu ZhangBiostatistics/Epidemiology/Research Design (BERD) Core, Center for Clinical and Translational Sciences, The University of Texas Health Science Center at Houston, Houston, TX, United States.
Mohammad H RahbarBiostatistics/Epidemiology/Research Design (BERD) Core, Center for Clinical and Translational Sciences, The University of Texas Health Science Center at Houston, Houston, TX, United States.
Amirali TahananBiostatistics/Epidemiology/Research Design (BERD) Core, Center for Clinical and Translational Sciences, The University of Texas Health Science Center at Houston, Houston, TX, United States.
Cici BauerDepartment of Biostatistics and Data Science, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, United States.
Marcia C de Oliveira OttoDepartment of Epidemiology, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, United States.
Alanna C MorrisonDepartment of Epidemiology, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, United States.
Belinda ReiningerDepartment of Epidemiology, Human Genetics and Environmental Science, School of Public Health, The University of Texas Health Science Center at Houston, Brownsville, TX, United States.
Maria E FernandezDepartment of Health Promotion and Behavior Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Brownsville, TX, United States.

Funding

Convalescent Plasma to Limit Coronavirus Associated ComplicationsUL1TR003167 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KARP, DANIEL D, MCPHERSON, DAVID D · 2019 to 2023
$45.3M
Center for Clinical and Translational SciencesUM1TR004906 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Maria Eulalia Fernandez, LORNA H. MCNEILL · 2024 to 2026
$16.7M
Translational Research Support CoreP30ES030285 · NIEHS · BAYLOR COLLEGE OF MEDICINE · PI Cheryl L. Walker · 2019 to 2026
$14.7M
Addressing COVID-19 Testing Disparities in Vulnerable Populations Using a Community JITAI (Just in Time Adaptive Intervention) Approach: RADxUP Phase IIIU01TR004355 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BAUER, CICI, CRUM, MICHELLE · 2023 to 2023
$2.2M
NCATS NIH HHS U01 TR004355NCATS NIH HHS UL1 TR003167NCATS NIH HHS UM1 TR004906NIEHS NIH HHS P30 ES030285
6 · The paper itself

Abstract

Background: Our institution carried out a multi-center, group-randomized controlled trial to evaluate the effectiveness of two community-based interventions on promoting the uptake of COVID-19 testing and vaccination in three regions with high levels of health disparities in Texas. We selected Census Block Groups (CBGs) with high disparity for randomization. In each study region, selected CBGs were randomized into two intervention groups and one control group. An important goal was to ensure balanced distributions of two continuous covariates, the disparity index and population size, across study arms. In this paper, we describe a novel minimization method used to ensure balanced study arms. Methods: We employed a minimization method to balance distributions of disparity index and population size among the selected CBGs across three study groups. First, we used the means and standard deviations at the baseline to standardize covariates. Second, we used the maximum of pairwise Manhattan distances as the imbalance score. When randomizing a set of CBGs, we computed the imbalance scores for all possible assignments and used unequal allocation probabilities to implement randomization. We conducted a simulation study to evaluate the performance of the imbalance score. Results: In both the simulation study and the actual randomization results of the trial, minimization yielded balanced groups on the marginal distributions of the disparity index and population size. In the trial, the study groups were highly homogenous regarding the joint distribution of disparity index and population size (p = 0.91). Conclusion: The results indicate that the maximum of pairwise Manhattan distances is a practically useful imbalance score. Using this imbalance score, the minimization procedure satisfactorily balances the distribution of continuous covariates among three study groups.

Indexed as

Adaptive randomizationImbalance scoreMinimization

Identifiers

PMID39935750
PMCPMC11810699

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.